Results 151 to 160 of about 6,562 (195)

Restoring the glioblastoma tumor microenvironment by targeting C5a with the antagonist W54011. [PDF]

Sci Rep
Oh Y, Yoo J, Lee D, Ko B, Hong JP, Moon JH, Kim EH, Chang JH, Kim YC, Kang SG.   +9 more
europepmc   +1 more source

The life-and-death struggle between the complement system and pathogens: Mechanisms of elimination, evasion tactics, and translational potential. [PDF]

Virulence
Lian S, Liu J, Yang Y, Zhu G, Xia P.
europepmc   +1 more source

Complement updates in optic neuritis. [PDF]

Front Neurol
He Y, Guo K, Xin J.
europepmc   +1 more source

Emerging role of complement system in the induction of neuroinflammation in adenylosuccinate lyase deficiency disorder. [PDF]

Brain Behav Immun Health
Magnusen AF, Hopkin RJ, Vorhees C, Wilson E, Moehlman M, Hallinan B, Erickson C, DelBello MP, Marsili L, Coufal NG, Pandey MK.   +10 more
europepmc   +1 more source

ACSL4 Drives C5a/C5aR1-Calcium-Induced Fibroblast-to-Myofibroblast Transition in a Bleomycin-Induced Mouse Model of Pulmonary Fibrosis. [PDF]

Biomolecules
Ren T, Shi J, Zhuang L, Su R, Lai Y, Yang N.   +5 more
europepmc   +1 more source

The novel B-cell epitope peptide vaccine, MAX449, exhibits significant anti-tumor efficacy and enhances the therapeutic effects of PD-1 antibodies on tumors by modulating the activity of PMN-MDSCs. [PDF]

Theranostics
Yang H, Han X, Deng B, Zhao Y, Zhao J, Wu Y, Liu G, Zeng S, Wang S, Shen Z, Wang L, Sun Z, Lu W, Wu Y, Chen J.   +14 more
europepmc   +1 more source

Complement's involvement in allergic Th2 immunity: a cross-barrier perspective. [PDF]

J Clin Invest
Thomas SA, Lajoie S.
europepmc   +1 more source

Afucosylated IgG Promote Thrombosis in Mouse Injected with SARS-CoV-2 Spike Expressing Megakaryocytes. [PDF]

Int J Mol Sci
Mabrouk M, Atifi F, Wahnou H, Allaoui A, Zaid N, Naya A, Agbani EO, Khalki L, Khyatti M, Tijani Y, Akarid K, Arnoult D, Abou-Saleh H, El Faqer O, Labied S, Ammara M, Guessous F, Jalali F, Zaid Y.   +18 more
europepmc   +1 more source

Complement anaphylatoxins: Potential therapeutic target for diabetic kidney disease. [PDF]

Diabet Med
Ma J, Yiu WH, Tang SCW.
europepmc   +1 more source

Aberrant systemic acute-phase complement responses in conjunction with soluble CR1 attribute to varying grades of dengue disease severity. [PDF]

Front Immunol
Anshad AR, Saravanan S, Murugesan A, Vighnesh R, Raju S, Kannan R, Yong YK, Larsson M, Shankar EM.   +8 more
europepmc   +1 more source